The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA3/(Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 3907-3915

  Huang, Yue ^a,b   Khorchid, Ahmad ^b   Gabor, Juliana ^b   Wang, Jing ^a   Li, Xuguang ^a   Darlix, Jean Luc ^c   Wainberg, Mark A ^a,b   Kleiman, Lawrence ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS NUCLEOCAPSID; VIRUS TRANSCRIPTION;

EID: 0031977659     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.3907-3915.1998     Document Type: Article

References (42)

1. Trp primer is required for efficient initiation of reverse transcription. J. Virol. 66:2464-2472.
2. Aiyar, A., Z. Ge, and J. Leis. 1994. A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J. Virol. 68:611-618.
3. Lys3-primed (-) strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs. J. Biol. Chem. 271:9054-9061.
4. Lys3 interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc. Natl. Acad. Sci. USA 93:10063-10068.
5. Barat, C., V. Lullien, O. Schatz, G. Keith, and J. L. Darlix. 1989. HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J. 8:3279-3285.
6. Barat, C., O. Schatz, S. Le Grice, and J.-L. Darlix. 1993. Analysis of the interactions of HIV-1 replication primer tRNALys3 with nucleocapsid protein and reverse transcriptase. J. Mol. Biol. 231:185-190.
7. Berkowitz, R., J. Fisher, and S. P. Goff. 1996. RNA packaging, p. 177-218. In H. G. Krausslich (ed.), Morphogenesis and maturation of retroviruses, vol. 214. Springer-Verlag, Berlin, Germany.
8. Bowles, N. E., P. Damay, and P.-F. Spahr. 1993. Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67:623-631.
9. Chomczynski, P., and N. Sacchi. 1987. RNA isolation from cultured cells. Anal. Biochem. 162:156-159.
10. Crawford, S., and S. P. Goff. 1985. A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J. Virol. 53:899-907.
11. Dannull, J., A. Surovoy, G. Jung, and K. Moelling. 1994. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 13:1525-1533.
12. De Rocquigny, H., C. Gabus, A. Vincent, M.-C. Fournie-Zaluski, B. Roques, and J.-L. Darlix. 1992. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. USA 89:6472-6476.
13. Gheysen, D., E. Jacobs, F. de Foresta, C. Thiriart, M. Francotte, D. Thines, and M. De Wilde. 1989. Assembly and release of HIV-1precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112.
14. Gorelick, R. J., D. J. Chabot, A. Rein, L. E. Hendersen, and L. O. Arthur. 1993. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036.
15. Gorelick, R. J., J. S. M. Nigida, J. J. W. Bess, L. O. Arthur, L. E. Henderson, and A. Rein. 1990. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64:3207-3211.
16. Hong, S. S., and P. Boulanger. 1993. Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells. J. Virol. 67:2787-2798.
17. Lys incorporation into HIV-1. J. Virol. 71:4378-4384.
18. Lys into HFV-1. J. Virol. 68:7676-7683.
19. Lys on the viral genome exists in unextended and two base-extended forms within mature human immunodeficiency virus type 1. J. Virol. 71:726-728.
20. Lys3 (template/primer) complex. J. Mol. Biol. 247:236-250.
21. Lys3. EMBO J. 15:917-924.
22. Isel, C., R. Marquet, G. Keith, C. Ehresmann, and B. Ehresmann. 1993. Modified nucleotides of tRNALys3 modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J. Biol. Chem. 268:25269-25272.
23. Jiang, M., J. Mak, A. Ladha, E. Cohen, M. Klein, B. Rovinski, and L Kleiman. 1993. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J. Virol. 67:3246-3253.
24. Kaye, J. F., J. H. Richardson, and A. M. L. Lever. 1995. cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging. J. Virol. 69:6588-6592.
25. Khan, R., and D. P. Giedroc. 1992. Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. 267:6689-6695.
26. Gln2 as a primer in an in vitro primer-utilization assay. Proc. Natl. Acad. Sci. USA 89:9652-9656.
27. Levy, J. A, M. C. Cheng, D. Dina, and P. A. Luciw. 1986. AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science 232:998-1001.
28. Lys into human immunodeficiency virus type 1 particles. J. Virol. 68:2065-2072.
29. gag-pol incorporation into HIV-1. J. Mol. Biol. 265:419-431.
30. Mergener, K., M. Facke, R. Welker, V. Brinkmann, H. R. Gelderblom, and H. G. Krausslich. 1992. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology 186:25-39.
31. Ottmann, M., C. Gabus, and J.-L. Darlix. 1995. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 69:1778-1784.
32. gag and is incorporated into virus-like particles. J. Virol. 66:6304-6313.
33. Poon, D. T. K., J. Wu, and A. Aldovini. 1996. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J. Virol. 70:6607-6616.
34. Prats, A. C., L. Sarih, C. Gabus, S. Lirvak, G. Keith, and J. L. Darlix. 1988. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 7:1777-1783.
35. Rein, A. 1994. Retroviral RNA packaging: a review. Arch. Virol. Suppl. 9:513-522.
36. Rein, A., D. P. Harvin, J. Mirro, S. M. Ernst, and R. J. Gorelick. 1994. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus. J. Virol. 68:6124-6129.
37. Smith, A. J., M. I. Cho, M. L. Hammarskjöld, and D. Rekosh. 1990. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 64:2743-2750.
38. gag-pol from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 67:2266-2275.
39. Srinivasakumar, N., M.-L. Hammarskjöld, and D. Rekosh. 1995. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J. Virol. 69:6106-6114.
40. Stewart, L., G. Schatz, and V. M. Vogt. 1990. Properties of avian retrovirus particles defective in viral protease. J. Virol. 64:5076-5092.
41. Terwilliger, E. F., E. A. Cohen, Y. C. Lu, J. G. Sodroski, and W. A. Haseltine. 1989. Functional role of human immunodeficiency virus type 1 Vpu. Proc. Natl. Acad. Sci. USA 86:5163-5167.
42. Zhang, Y., and E. Barklis. 1995. Nucleocapsid protein effects in the specificity of retrovirus RNA encapsidation. J. Virol. 69:5716-5722.